1. Home
  2. NOTV vs MYO Comparison

NOTV vs MYO Comparison

Compare NOTV & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTV
  • MYO
  • Stock Information
  • Founded
  • NOTV 1974
  • MYO 2004
  • Country
  • NOTV United States
  • MYO United States
  • Employees
  • NOTV N/A
  • MYO N/A
  • Industry
  • NOTV Biotechnology: Pharmaceutical Preparations
  • MYO Industrial Specialties
  • Sector
  • NOTV Health Care
  • MYO Health Care
  • Exchange
  • NOTV Nasdaq
  • MYO Nasdaq
  • Market Cap
  • NOTV 46.7M
  • MYO 44.6M
  • IPO Year
  • NOTV 1997
  • MYO 2017
  • Fundamental
  • Price
  • NOTV $1.39
  • MYO $1.04
  • Analyst Decision
  • NOTV Strong Buy
  • MYO Strong Buy
  • Analyst Count
  • NOTV 1
  • MYO 3
  • Target Price
  • NOTV $5.00
  • MYO $7.83
  • AVG Volume (30 Days)
  • NOTV 446.2K
  • MYO 2.0M
  • Earning Date
  • NOTV 08-06-2025
  • MYO 11-05-2025
  • Dividend Yield
  • NOTV N/A
  • MYO N/A
  • EPS Growth
  • NOTV N/A
  • MYO N/A
  • EPS
  • NOTV N/A
  • MYO N/A
  • Revenue
  • NOTV $505,299,000.00
  • MYO $40,760,091.00
  • Revenue This Year
  • NOTV $5.64
  • MYO $25.69
  • Revenue Next Year
  • NOTV $5.16
  • MYO $23.52
  • P/E Ratio
  • NOTV N/A
  • MYO N/A
  • Revenue Growth
  • NOTV 0.85
  • MYO 93.08
  • 52 Week Low
  • NOTV $1.15
  • MYO $0.80
  • 52 Week High
  • NOTV $6.48
  • MYO $7.17
  • Technical
  • Relative Strength Index (RSI)
  • NOTV 42.19
  • MYO 49.48
  • Support Level
  • NOTV $1.41
  • MYO $0.87
  • Resistance Level
  • NOTV $1.57
  • MYO $1.07
  • Average True Range (ATR)
  • NOTV 0.12
  • MYO 0.08
  • MACD
  • NOTV 0.02
  • MYO 0.04
  • Stochastic Oscillator
  • NOTV 31.19
  • MYO 81.95

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).

Share on Social Networks: